Dengue Vaccine
Description
Results from an early trial for a vaccine for Dengue fever. Patients were randomized into two groups. Patients in the treatment group received the vaccine, and those in the control group received a placebo. After 6 months, each patient was injected with a weaker virus of Dengue. Researchers subsequently took blood measurements, inspecting if any virus was present, and also reported if any rash developed.
Usage
dengue
Format
A data frame with 30 rows and 2 variables.
- condition
What the patient received, either the vaccine or a placebo.
- virus_in_blood
Whether a patient had Dengue virus present in her / his blood.
- develop_rash
Whether a patient developed a rash.
Source
Hayden EC. 2016. Dengue vaccine aces trailblazing trial. Nature. https://doi.org/10.1038/nature.2016.19576